NR0B2 and fatty liver disease: In a diet-induced steatosis model, CH25H has been reported to positively regulate CYP7A1 and CYP27A1 and reduce small heterodimer partner (SHP), thus increasing the synthesis and excretion of BAs, drastically reducing the high-fat diet-induced hepatic steatosis (27).